TRAW
Traws Pharma
$0.30
−$0.06 (−16.39%)Oct 29, 2026
Key metrics
The numbers that frame TRAW today
- Market cap
- $4.63M
- ROIC
- 241.7%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.30
- 52wk High
- $3.23
Growth
Revenue and earnings trend for TRAW
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TRAW
Is Traws Pharma a good buy?
No. Traws Pharma has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of TRAW?
Traws Pharma's market capitalization is $4.63M.
What is the 52-week high for TRAW stock?
The 52-week high for Traws Pharma is $3.23. The current close of $0.30 is 90.7% below that high.
What is the 52-week low for TRAW stock?
The 52-week low for Traws Pharma is $0.30. The current close of $0.30 is 0.3% above that low.
Does TRAW stock pay dividends?
Traws Pharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TRAW?
Traws Pharma's Debt / Equity ratio is 0.